Improved Pseudomonas aeruginosa detection through the development of an engineered reporter bacteriophage
Biosensors and Bioelectronics · 2025-12 · 289 · 117907
DOI: 10.1016/j.bios.2025.117907 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2025-12. Verfasst von Sílvio B Santos und 3 weiteren Autor:innen. Beteiligte Einrichtung: CEB - Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, Braga, Portugal; LABBELS - Associate Laboratory, Braga, Guimarães, …. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections, Biosensing Techniques, Luciferases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, European Commission.
Abstract (Originalsprache)
Currently, there is a critical need for the rapid and accurate detection of Pseudomonas aeruginosa, a major pathogen responsible for nosocomial infections and high mortality rates due to its antibiotic resistance and virulence. To address this challenge, a new method is here described based on the development of a genetically engineered reporter bacteriophage that expresses the NLuc luciferase upon bacterial infection. The NLuc luciferase gene was inserted in the previously characterized vB_PaeP_PE3 P. aeruginosa phage, using the yeast-based phage-engineering platform. The expression of the NLuc luciferase, driven by endogenous phage promoters, ensures high-level reporter expression during bacterial infection, producing a strong luminescence signal upon substrate addition. The ability to detect viable P. aeruginosa cells as few as 10^2 CFU/mL within 7 h and approximately 1 CFU/mL within 24 h with a 100 % specificity, significantly reduces the turnaround time compared to traditional methods. Moreover, the method was successfully validated in artificially contaminated blood samples, highlighting its potential for clinical applications in diverse settings, including resource-limited areas due to its simplicity and reduced costs. This innovative approach promises to improve P. aeruginosa diagnosis, facilitating timely and appropriate antimicrobial therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CEB - Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, Braga, Portugal; LABBELS - Associate Laboratory, Braga, Guimarães, Portugal. Electronic address: silviosantos@ceb.uminho.pt.
- CEB - Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, Braga, Portugal.
- CEB - Centre of Biological Engineering, Universidade Do Minho, Campus de Gualtar, Braga, Portugal; LABBELS - Associate Laboratory, Braga, Guimarães, Portugal. Electronic address: priscilapires@ceb.uminho.pt.
Förderung
- Fundação para a Ciência e a Tecnologia
- European Commission
Zitieren
APA
Santos, S. B., Costa, M. J., Meneses, L., & Pires, D. P. (2025). Improved Pseudomonas aeruginosa detection through the development of an engineered reporter bacteriophage. Biosensors and Bioelectronics, 289, 117907. https://doi.org/10.1016/j.bios.2025.117907
Vancouver
Santos SB, Costa MJ, Meneses L, Pires DP. Improved Pseudomonas aeruginosa detection through the development of an engineered reporter bacteriophage. Biosensors and Bioelectronics. 2025;289:117907. doi:10.1016/j.bios.2025.117907
BibTeX
@article{Santos2025,
author = {Santos, Sílvio B and Costa, Maria João and Meneses, Luciana and Pires, Diana Priscila},
title = {Improved Pseudomonas aeruginosa detection through the development of an engineered reporter bacteriophage},
journal = {Biosensors and Bioelectronics},
year = {2025},
volume = {289},
pages = {117907},
doi = {10.1016/j.bios.2025.117907}
}
EUVIMED